Background: Each year thousands of pregnant women experiencing threatened premature labour (TPL) travel considerable distances across the state to access higher levels of care, but only a small proportion of these women give birth to a premature baby. Women from regional areas are required to move away from their home, children and support networks because of a perceived risk of birthing in a centre without neonatal intensive care facilities. The WANTe study examines the experience of women undergoing antenatal transfer for TPL in New South Wales (NSW) with a view to influence policy and service provision in NSW.
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Methods: Thirteen semi-structured in-depth interviews were held with women across five tertiary referral sites across NSW and the ACT, and analysed until saturation for themes.
Results: Seven urban and six rural women interviews were used in the analysis. Women and their families were all negatively affected by antenatal transfer. Factors that helped enable a positive experience were; enhanced sense of safety in the tertiary unit, and individual qualities with staff. Factors that contributed to negative experiences were; inadequate and conflicting information, and no involvement or choice in the clinical decisionmaking process to move to another facility.
Conclusions: Antenatal transfer is a stressful experience for women and their families. The provision of high quality information, and the inclusion of women's perception of risk in the clinical decision making process will improve the experience for women and their families. Email: ruth.lim@monashhealth.org Background: Neonatal early-onset sepsis (EOS) is an invasive bacterial infection with an incidence of 0.83 per 1000 live births. Current risk-based management guidelines result in large numbers of newborns being investigated and treated empirically with antibiotics. We aimed to evaluate the neonatal sepsis calculator 1 in the term neonatal population of a Victorian tertiary perinatal centre and determine if culture-positive EOS was appropriately identified and managed, and if empirical antibiotic use was reduced. Methods: Obstetric risk factors, clinical presentation and management of babies born ≥ 37 weeks and ≥ 2500 g between July 2014 and June 2015 at Monash Medical Centre (MMC) were collected. MMC has 4000 births annually and EOS incidence rate of 1/1000 live births. The sepsis calculator was applied to babies with culturepositive EOS and babies who received management for proven, suspected or possible EOS at varying baseline EOS incidence rates.
COMPARISON OF CURRENT RISK-BASED GUIDELINES FOR PREVENTION OF NEONATAL EARLY-ONSET SEPSIS WITH A SEPSIS CALCULATOR
Results: There were five culture-positive EOS cases, all of which were appropriately identified and managed by the sepsis calculator. 407 babies were investigated or managed for suspected EOS and 375 (92%) received IV antibiotics. At baseline EOS incidence rates of 0.5, 1 and 2 per 1000 live births, the sepsis calculator reduced IV antibiotic use by 81%, 76% and 71% respectively.
Conclusions: The sepsis calculator safely identified culturepositive EOS, and reduced empirical IV antibiotic use at differing baseline EOS rates. Use of the sepsis calculator has been implemented and prospective data collection is ongoing. Background: Sjogren's syndrome (SS) is an autoimmune disease which, if not well controlled preconception, has the potential to deteriorate during pregnancy. The obstetric patient with SS is at risk of worsening renal function, disease relapse, and fetal loss. SS also predisposes the foetus to adverse perinatal outcomes, such as congenital heart block, growth restriction, and preterm birth. Some antirheumatic drugs can be teratogenic. We present a case of a woman who falls pregnant several years after the diagnosis of SS.
Case: A 33-year old multiparous woman, CM, presents for her first pregnancy appointment years after the diagnosis of SS. She is known to a nephrologist and had developed interstitial nephritis, leading to the commencement of hydroxychloroquine to maintain remission. CM was managed by the high-risk pregnancy team in liaison with obstetric medicine and her nephrologist. CM continued hydroxychloroquine with no changes to dosage throughout pregnancy. She received regular investigations to monitor renal function and disease activity as well as growth ultrasounds to assess fetal wellbeing. CM subsequently had an uncomplicated delivery of a healthy male baby at term.
Conclusions: It is essential for women with autoimmune diseases to receive preconception counselling and aim to achieve remission or stable disease state before trying to fall pregnant. Once the disease is stable, SS is much less likely to flare or cause adverse perinatal outcomes. Close surveillance of the mother and baby is important so early referral to rheumatology or obstetric medicine can occur, allowing prompt treatment as well as delivery planning. 
